A new weapon to disable bacteria discovered

White blood cells imprison bacteria in tightly fitting compartments or vacuoles. Within these vacuoles, the cells release noxious substances that kill the bacteria. This is why most of the time our bodies can take care of small wounds or mild infections. Sometimes, however, we get infected with bacteria equipped with highly evolved defenses that target white blood cells, the very cells that are supposed to defend us. A case in point is dysentery, a serious, bloody form of diarrhea. It is caused by bacteria called Shigella. This is a devastating disease that claims millions of lives every year, especially among children in the developing world.

Shigella uses disease-causing (virulent) proteins to attack human cells. Shigella uses these virulent proteins to invade any cell in the body and then to escape from the cellular prison - the vacuole. Weinrauch and Zychlinsky recognized a contradiction: if Shigella escapes the vacuolar prison, the infection should always be lethal. Yet, most people recover after suffering an acute infection.

Weinrauch and Zychlinsky reasoned that the answer could be found in a specialized white blood cell - the neutrophil. Neutrophils were prime suspects for two reasons. Firstly, they are very abundant in the response to Shigella infections, and secondly, they are equipped with defense mechanisms that kill bacteria when confined to a vacuolar prison. In collaboration with Jerry Weiss, now at Iowa University, the investigators found that surprisingly, neutrophils, unlike any other type of cells, can enclose Shigella within the vacuoles.

Investigations into the reason why Shigella is enclosed within neutrophil vacuoles led Weinrauch and Zychlinsky to discover how the neutrophil can neutralize not only Shigella but also other disease causing bacteria. Neutrophils produce an enzyme, elastase, which can destroy Shigella's escape proteins with amazing efficiency before they can leave the vacuole. In this manner

Contact: Arturo Zychlinsky

Page: 1 2

Related biology news :

1. $18 million bioinformatics center to become weapon against deadly diseases
2. Synthesized molecules studied as weapon to stop cell division in cancer cells
3. Are bacteria turning our own weapons against us?
4. A shrinking sink? Carbon fertilization may be flimsy weapon against warming
5. With natures help, a better vision system for smart weapons
6. War on germs gets cutting-edge weapon from ancient world technique
7. An unlikely new weapon against a deadly bacteria in oysters: A virus
8. Molecular machine could develop drugs for bioweapons victims
9. Hemorrhagic fever viruses examined as potential bioweapons
10. Australian frog is first to make its own chemical weapons
11. CDC MMWR; tularemia and its potential use as a biological weapon

Post Your Comments:

(Date:8/3/2020)... ... August 03, 2020 , ... ... new partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing ... their laboratory supply chain for more than 10 years. Early in the COVID-19 ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... therapeutics product portfolio with a near term focus on Type 2 diabetes and ... commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin ...
(Date:7/18/2020)... , ... July 16, 2020 , ... ... demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device to ... study reported that the Neoasis™ device attenuated the alarm sounds from patient monitors, ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... 06, 2020 , ... Bio-IT World has announced the winners ... the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance ... highlighting outstanding examples of how technology innovations and strategic initiatives can be powerful ...
(Date:6/28/2020)... , ... June 25, 2020 , ... The Indoor Lab, ... of Safe Space™ for businesses of all types to ensure cleanliness, distancing and occupancy ... , A Safe Space™ enabled business will provide a health performance index system ...
(Date:6/23/2020)... ... , ... Kerafast Inc. , developers of an online ... of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by ... entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. , ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, a biopharmaceutical ... has filed an Investigational New Drug application (IND) with the U.S. Food & ... drug candidate NBTX-001 in patients with panic disorder (PD). , "Adding a PD ...
Breaking Biology Technology:
Cached News: